The monoethyl ester of meconic acid is an active site inhibitor of HCVNS5B RNA-dependent RNA polymerase

被引：50

作者：

Pace, P ^{[1
]}

Nizi, E ^{[1
]}

Pacini, B ^{[1
]}

Pesci, S ^{[1
]}

Matassa, V ^{[1
]}

De Francesco, R ^{[1
]}

Altamura, S ^{[1
]}

Summa, V ^{[1
]}

机构：

[1] IRBM MRL Rome, Dept Med Chem & Biochem, I-00040 Pomezia, Italy

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 12期

关键词：

D O I：

10.1016/j.bmcl.2004.03.087

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Screening of the in-house sample collection for compounds with HCV NS5B RNA dependent RNA polymerase inhibition led to the identification of a new lead. Afterwards, we discovered that the screening lead, rather than containing the expected structure 1, was comprised of roughly a 1:1 mixture of meconic acid 2 and its monoethyl ester 3, with all inhibitory potency residing with 3. We propose that this compound shares critical common features for activity with alpha,gamma-diketoacids inhibitors previously discovered by our group. SAR around this molecule will be presented to provide an improved basis for structure-based ligand design. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：3257 / 3261

页数：5

共 50 条

[1] Kinetic characterization of HCVNS5B RNA-dependent RNA polymerase
Tsai, YC
Johnson, KA
BIOPHYSICAL JOURNAL, 2003, 84 (02) : 30A - 30A
[2] Canonical 3′-deoxyribonucleotides as a chain terminator for HCVNS5B RNA-dependent RNA polymerase
Shim, J
Larson, G
Lai, V
Naim, S
Wu, JZ
ANTIVIRAL RESEARCH, 2003, 58 (03) : 243 - 251
[3] Expression and purification of untagged full-length HCVNS5B RNA-dependent RNA polymerase
Wang, QM
Johnson, RB
Chen, DY
Léveque, VJP
Ren, JX
Hockman, MA
Abe, K
Hachisu, T
Kondo, Y
Isaka, Y
Sato, A
Fujiwara, T
PROTEIN EXPRESSION AND PURIFICATION, 2004, 35 (02) : 304 - 312
[4] Discovery and SAR studies of a novel class of HCVNS5B RNA-dependent RNA polymerase inhibitors.
Nguyen-Ba, N
Das, SK
Poisson, C
Reddy, TJ
Proulx, M
Pereira, O
Courchesne, M
Roy, C
Yannopoulos, C
Halab, L
Chan, L
Zhang, MQ
Bethell, R
L'Heureux, L
David, M
Hamel, M
Nicolas, O
Bédard, J
ANTIVIRAL RESEARCH, 2003, 57 (03) : A85 - A85
[5] Structure-activity relationship (SAR) studies of quinoxalines as novel HCVNS5B RNA-dependent RNA polymerase inhibitors
Rong, Frank
Chow, Suetying
Yan, Shunqi
Larson, Gary
Hong, Zhi
Wu, Jim
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (06) : 1663 - 1666
[6] Phenyldihydroxypyrimidines as HCVNS5B RNA dependent RNA polymerase inhibitors. Part II: Sulfonamides
Ponzi, S
Giuliano, C
Donghi, M
Poma, M
Matassa, VG
Stansfield, I
LETTERS IN DRUG DESIGN & DISCOVERY, 2005, 2 (06) : 456 - 461
[7] Phenyldihydroxypyrimidines as HCVNS5B RNA dependent RNA polymerase inhibitors. Part 1: Amides and ureas
Crescenzi, B
Poma, M
Ontoria, JM
Marchetti, A
Nizi, E
Matassa, VG
Gardelli, C
LETTERS IN DRUG DESIGN & DISCOVERY, 2005, 2 (06) : 451 - 455
[8] Isothiazoles as active-site inhibitors of HCVNS5B polymerase
Yan, Shunqi
Appleby, Todd
Gunic, Esmir
Shim, Jae Hoon
Tasu, Tania
Kim, Hongwoo
Rong, Frank
Chen, Huaming
Hamatake, Robert
Wu, Jim Z.
Hong, Zhi
Yao, Nanhua
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (01) : 28 - 33
[9] Identification of [(naphthalene-1-carbonyl)-amino]-acetic acid derivatives as nonnucleoside inhibitors of HCVNS5B RNA dependent RNA polymerase
Gopalsamy, A
Lim, K
Ellingboe, JW
Krishnamurthy, G
Orlowski, M
Feld, B
van Zeijl, M
Howe, AYM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (16) : 4221 - 4224
[10] Discovery of a novel class of HCVNS5B RNA dependent RNA polymerase inhibitors:: SAR studies and activity in replicon cells
Chan, L
Reddy, TJ
Proulx, M
Das, SK
Pereira, O
Courchesne, M
Roy, C
Yannopoulos, C
Poisson, C
Nguyen-Ba, N
Halab, L
Bethell, R
Zhang, MQ
David, M
L'Heureux, L
Bédard, J
Hamel, M
Nicolas, O
ANTIVIRAL RESEARCH, 2003, 57 (03) : A76 - A76

← 1 2 3 4 5 →